| Cash Flow | 2025-09-27 | 2025-06-28 |
|---|---|---|
| Revenue-Reportable Segment | 727,561 | - |
| Adjusted cost of revenue-Reportable Segment | 313,343 | - |
| Adjusted sales and marketing operating expenses-Reportable Segment | 158,295 | - |
| Adjusted research and development operating expenses-Reportable Segment | 119,887 | - |
| Adjusted general and administrative operating expenses-Reportable Segment | 57,438 | - |
| Other segment items-Reportable Segment | 66,883 | - |
| Income taxes-Reportable Segment | -9,056 | - |
| Interest income and other expenses, net | -10,099 | - |
| Income taxes | 10,099 | - |
| Net income (loss) | 10,672 | -4,986 |
| Stock-based compensation | 65,976 | 45,357 |
| Depreciation and amortization | 13,310 | 8,613 |
| Deferred income taxes | 8,778 | -1,285 |
| Net accretion of available-for-sale securities | 3,001 | 2,137 |
| Accounts receivable, net | 8,144 | -16,245 |
| Inventory | 5,255 | 7,795 |
| Prepaid expenses and other assets | -11,297 | -13,752 |
| Accounts payable | -71 | 2,284 |
| Accrued liabilities | -5,936 | -10,387 |
| Deferred revenue | -3,702 | -1,748 |
| Other long-term liabilities | 4,983 | -1,320 |
| Net cash provided by operating activities | 88,907 | 56,593 |
| Purchases of property and equipment | 13,670 | 8,045 |
| Purchases of marketable securities | 166,936 | 95,116 |
| Sales of marketable securities | 11,362 | 11,362 |
| Maturities of marketable securities | 168,350 | 117,679 |
| Net cash used in investing activities | -894 | 25,880 |
| Proceeds from common stock issuances related to employee benefit plans | 40,821 | 24,197 |
| Repurchases of common stock | 77,010 | 73,531 |
| Net cash provided by (used in) financing activities | -36,189 | -49,334 |
| Effect of exchange rate changes on cash and cash equivalents | 26 | 237 |
| Net increase (decrease) in cash and cash equivalents | 51,850 | 33,376 |
| Cash and cash equivalents at beginning of period | 43,162 | - |
| Cash and cash equivalents at end of period | 95,012 | - |
CALIX, INC (CALX)
CALIX, INC (CALX)